User profiles for Sameer Al Diffalha

Sameer Al Diffalha

University of Alabama at Birmingham (UAB)
Verified email at uabmc.edu
Cited by 818

Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?

F Bril, S Al Diffalha, M Dean… - Journal of …, 2021 - journal-of-hepatology.eu
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been
associated with the development of autoimmune processes. 1–4 Molecular mimicry has been …

Breast implant capsule-associated squamous cell carcinoma: report of 2 patients

…, SS Badve, S Al Diffalha - … Journal of Surgical …, 2022 - journals.sagepub.com
Breast implant augmentation is a low-risk procedure with few life-threatening complications.
Capsular contracture and rupture/leakage of the implant are the most common …

Primary liver cancers—Part 1: Histopathology, differential diagnoses, and risk stratification

K Jiang, S Al-Diffalha, BA Centeno - Cancer control, 2018 - journals.sagepub.com
Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) are the 2 most common
primary malignant liver tumors, with hepatocellular and bile ductular differentiation, respectively. …

[HTML][HTML] MTHFD1L, a folate cycle enzyme, is involved in progression of colorectal cancer

S Agarwal, M Behring, K Hale, S Al Diffalha… - Translational …, 2019 - Elsevier
Identification of new molecular targets is needed for the treatment of colorectal cancer (CRC).
Methylenetetrahydrofolate dehydrogenase 1 like (MTHFD1L), an enzyme in the folate cycle…

Analysis of the immune landscape of small bowel neuroendocrine tumors

M Cives, J Strosberg, S Al Diffalha… - Endocrine-related …, 2019 - erc.bioscientifica.com
Immune checkpoint inhibitors have shown promising results in different cancers, and
correlation between immune infiltration, expression of programmed death-ligand 1 (PD-L1) by …

[HTML][HTML] PAICS, a purine nucleotide metabolic enzyme, is involved in tumor growth and the metastasis of colorectal cancer

…, SAH Balasubramanya, C Hardy, SA Diffalha… - Cancers, 2020 - mdpi.com
The identification of colorectal cancer (CRC) molecular targets is needed for the
development of drugs that improve patient survival. We investigated the functional role of …

DCZ0415, a small‐molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β‐catenin pathway in …

…, M Behring, DS Chandrashekar, SA Diffalha… - Molecular …, 2022 - Wiley Online Library
Thyroid receptor‐interacting protein 13 (TRIP13), a protein of the AAA‐ATPase family, is
upregulated in various human cancers, including colorectal cancer (CRC). This study focused …

TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status

…, N Gupta, P Bajpai, A Elkholy, S Al Diffalha… - Molecular …, 2020 - Wiley Online Library
Overexpression of TRIP13, a member of the AAA‐ATPase family, is linked with various cancers,
but its role in metastasis is unknown in colorectal cancer (CRC). In the current study, we …

[HTML][HTML] Targeting P4HA1 with a small molecule inhibitor in a colorectal cancer PDX model

…, N Gupta, A Elkholy, S Al Diffalha… - Translational …, 2020 - Elsevier
Deposition, remodeling, and signaling of the extracellular matrix facilitate tumor growth and
metastasis. Here, we demonstrated that an enzyme, collagen prolyl 4-hydroxylase, alpha …

[HTML][HTML] Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer

…, M Nearing, MC McLeod, S Al Diffalha… - Journal of Biological …, 2022 - ASBMB
Locally advanced rectal cancer is typically treated with chemoradiotherapy followed by surgery.
Most patients do not display a complete response to chemoradiotherapy, but resistance …